Burning Rock Announces the Launch of China’s First Prospective Pan-Cancer Multi-omics Early Detection Study
With support from the National Cancer Center, PRESCIENT is the first blood-based cancer screening and early detection study using a multi-omics approach in China.
- With support from the National Cancer Center, PRESCIENT is the first blood-based cancer screening and early detection study using a multi-omics approach in China.
- Burning Rock\xe2\x80\x99s pan-cancer early detection technology has achieved strong initial results and I am very excited to work with Burning Rock and other clinical centers on this study.
- Yusheng Han, Founder and CEO of Burning Rock, said, \xe2\x80\x9cPan-cancer early detection is one of Burning Rock\xe2\x80\x99s strategic priorities.
- The launch of the PRESCIENT study after the PREDICT study demonstrates our unwavering commitment to early cancer detection.